+
Site Tour
TRICLIP™
TRICUSPID
VALVE REPAIR
TRANSCATHETER
EDGE-TO-EDGE REPAIR (TEER)

 

TriClip™ Transcatheter Edge-to-Edge Repair (TEER) offers a minimally invasive
treatment option for patients with symptomatic, severe tricuspid regurgitation (TR)
who are at high risk for surgery.1

EXCEPTIONAL
SAFETY4,5

MAXIMIZED
EFFECTIVENESS4,5

LIFE-CHANGING
IMPACT3-5

The TriClip™ G4 Transcatheter Edge-to-Edge Repair System empowers you with stable navigation and precise delivery2 for complex conditions.

F/E Knob

S/L Knob

Steerable Guide Catheter

+/- Knob

Distal Curve

TriclipTM G4 Delivery System

Controlled Gripper Actuation

Actuator Knob

  • Flexes and extends delivery catheter to steer down to the valve plane

  • Enables movement in septal or lateral direction

  • Designed for the tricuspid anatomy2,4
    • Provides adequate height over the valve
    • Maintains coaxial position during steering and positioning
    • Allows sweeping away from the septum to optimize delivery catheter position while maintaining perpendicularity to the plane of the valve

  • Straightens or curves the guide to add or subtract height above the valve

  • Designed for direct access to the tricuspid valve2,15

    • Provides stability and precision during steering and positioning
    • Multiaxis steering to enable navigation across all lines of coaptation

  • Confirm and optimize leaflet capture

  • Implant and gripper line detachment

EPIC™ SUPRA AORTIC STENTED TISSUE VALVE FEATURES
1
2
3
4
5
6
7
8
    • Provides stability and precision during steering and positioning
    • Multiaxis steering to enable navigation across all lines of coaptation
  2. Flexes and extends delivery catheter to steer down to the valve plane
  3. Enables movement in septal or lateral direction
  4. Straightens and curves guide for height adjustment above the valve

  5. Designed for the tricuspid anatomy2,4

    • Provides adequate height over the valve
    • Maintains coaxial position during steering and positioning
    • Allows sweeping away from the septum to optimize delivery catheter while maintaining perpendicularity to the plane of the valve
  6. Designed for direct access to the tricuspid valve2,15
  7. Confirm and optimize leaflet grasping
  8. Simultaneous implant and gripper detachment
Building on a legacy of unmatched TEER expertise13

TriClip™ implants use the same proven leaflet repair technology as our MitraClip™ Transcatheter Edge-to-Edge Repair (TEER). TriClip TEER is the clip-based technology physicians know and trust, with a delivery system uniquely designed for the tricuspid valve.

TriClip™ Implant Features1

  • Elgiloy® implants with nitinol grippers
  • Polyester cover designed to promote tissue growth
  • Magnetic resonance conditional to 3 Tesla†


†Static magnetic field of 1.5 T or 3 T; maximum spatial gradient in static field of 4000 gauss/cm or less; maximum whole-body averaged specific absorption rate (SAR) of 2 W/kg for 15 minutes of scanning.
 

Optimized leaflet capture

Optimized leaflet capture for consistent TR reduction with the TriClip G4 TEER System

  • Wide grasp opening allows full leaflet insertion1
  • Designed to distribute retention forces along the entire inserted leaflet length11
  • Four or six rows of frictional elements designed to provide atraumatic leaflet engagement11
Broad range of sizes for tailored treatment

Four implant sizes are available for patient-specific therapy with the TriClip G4 TEER System.1

Connext
Live

Hear from the most respected KOLs in cardiovascular and stroke prevention, collaborate on best practice and be part of the CONNEXT community.

Find out more

 

 

TV

T-TEER: Transcatheter Tricuspid Valve Repair - cases, tips, and tricks

T-TEER: Transcatheter Tricuspid Valve Repair - cases, tips, and tricks

T-TEER: echo procedural approach

T-TEER: echo procedural approach for Transcatheter Tricuspid Repair

T-TEER: patient selection and current evidence

T-TEER: patient selection and current evidence for TR Repair

Anatomical overview of the AV Valves

Anatomical overview of the AV Valves and structures

Screening Transmission | Mitral focus

Screening Transmission | Mitral focus

F. Maisano, M. Swaans, M. Adam. M. Weber

TriClip - AVVS 1 year 1 minute Tricuspid - Video

The most significant moments of the past year | Tricuspid focus

MitraClip - AVVS 1 year 1 minute Mitral - Video

The most significant moments of the past year | Mitral focus

AV Valves Summit 2024 | Closing of Day 2

AV  Valves Summit 2024 | Closing of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Trending Controversies | AV Valves

Trending Controversies | AV Valves

R. S. Von Bardeleben, M. Sitges, D. Tchetche, M. Swaans, M. Taramasso, C. Trani, K. Gatenby, M. Adamo, M. Barreiro, A. Linke, V. Ninios, J. Odenstedt, S. Berti, N. Ajmone Marsan

Case Parade | Mitral focus

Case Parade | Mitral focus

M. Sitges,  V. Ninios, J. Van der Heyden, K. Gatenby, D. Arzamendi, M. Shuvy, M. Adam

References
  1. TriClip G4 System IFU. 
  2. Tests(s) performed and data on file at Abbott (RPT2118537)
  3. Estevez-Loureiro R. Real-world Outcomes for Tricuspid Edge-to-Edge Repair: Initial 2-year Outcomes from the bRIGHT Trial. Presented at PCR London Valves on November 19-21, 2023; London, UK.
  4. Adams D, Sorajja P, et al. TRILUMINATE Pivotal: Outcomes of All Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation. Presented at TCT on October 24,2023; San Francisco, CA; USA.
  5. Sorajja P, Whisenant B, Hamid N, et al. Transcatheter repair for patients with tricuspid regurgitation. NEJM. March 4, 2023. doi: 10.1056/NEJMoa2300525.
  6. Benfari G, Antoine C, Mille WL, et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019;140(3):196-206.
  7. Asmarats L, Puri R, Latib A, et al. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71(25):2935-2956.
  8. Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a public health crisis [published online ahead of print November 9, 2019]. Prog Cardiovasc Dis. 2019;62(6):447-451. Doi:10.1016/j.pcad.2019.10.009.
  9. Wong WK, Chen SW, Chou AH, et al. Late outcomes of valve repair versus replacement in isolated and concomitant tricuspid valve surgery: a nationwide cohort study. J Am Heart Assoc. 2020;9(8):e015637. doi:10.1161/JAHA.119.015637.
  10. Moraca RJ, Moon MR, Lawton JS, Guthrie TJ, Aubuchon KA, Moazami N, Pasque MK, Damiano RJ Jr. Outcomes of tricuspid valve repair and replacement: a propensity analysis. Ann Thorac Surg. 2009 Jan;87(1):83-8; discussion 88-9.
  11. Test(s) performed by and data on file at Abbott. (RPT2133700, RPT2122822-R, RPT2124838-R)
  12. www.mayoclinic.org. Assessed February 2024.
  13. Data on File at Abbott.
  14. Test(s) performed by and data on file at Abbott. (RPT2105461-R)
  15. Test(s) performed by and data on file at Abbott. (RPT2124196-R)

© Abbott 2024. All rights reserved. 9-EH-5-14379-01 08-2024 REV A

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline